Skip to content
Measurement of new oral anticoagulans
8th ECAT International Symposium 2012
Speaker
Titel
Abstract
Presentation
H. Mani
Measurement of new oral anticoagulans
Related items
Analytical Information :
6
Influence of DOAC Stop on coagulation assays in samples from patients on rivaroxaban or apixaban
Minimum citrate tube fill volume for routine coagulation testing
Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays
Comparison of two statistical software programs for determining reference intervals of screening coagulation assays
Analytical performance specifications for hemostasis parameters
The effect of Rivaroxaban on haemostasis assays; results from ECAT surveys
Cases :
5
Prekallikrein deficiency
Effect of high haematocrit levels on coagulation testing
A patient with mild haemophilia A
Lupus Anticoagulant-Hypoprothrombinemia Syndrome
Acquired Hemophilia A, case study
ECAT Documents :
45
External quality assessment of the manual tilt tube technique for prothrombin time testing: a report from the IFCC-SSC/ISTH Working Group on the Standardization of PT/INR
Thromboplastin
PT-Prothrombin Time and Prothrombin Time Ratio
Phospholipids
Intrinsic Pathway of Coagulation
Hemostasis
Extrinsic Pathway of Coagulation
Contact Activation
Common Pathway of Coagulation
Coagulation Cascade
Coagulation (Clotting)
Activated Partial Thromboplastin Time Test (APTT)
International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents
Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
International external quality assessment for measurements of direct oral anticoagulants: results and recommendations.
Laboratory assesment of direct and indirect thrombin inhibitors
The results of the workshop on inhibitor testing
New developments in laboratory tests
Desired tests for monitoring new anticoagulation drugs
An update on new anticoagulation drugs
Lupus Anticoagulant: Remarkable observations in ECAT surveys
How do laboratories interpret unexpected APTT prolongation?
Algoritm for Laboratory Investigations in Case of a prolonged APTT
Is therapeutic quality influenced by choice of thromboplastin?
Factor VIII inhibitor testing – a way to comparable test results
Pre-analytical Variables in the Hemostasis Laboratory
Slope and parallelism of APTT dilution curves: new insights
ECAT survey results on direct oral anticoagulant testing
Monitoring new oral anticoagulants-Practical approach
The future of anticoagulation
Thrombosis webinar 2021, Antiphospholipid Antibody, Anticoagulation bridging
Medical device thrombosis
The relevance of pre-operative hemostasis screening
Developmental haemostasis: consequences for clinical practice
Results of ECAT EQA programme on DOACS
Interference of DOACS in coagulation tests
Guidance for laboratory testing of DOACS
Interferences in Lupus testing
EFLM/EQALM on the laboratory diagnosis of a prolonged APTT
What information does the doctor expect from the laboratory? What kind of services can a laboratory deliver to the physician?
When Haemostasis Assays Mislead
Sinus thrombosis, past, present and future
Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories
Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands
Guidelines :
4
ICSH recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests
Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies (ICSH)
ICSH Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Update Recommendations for Laboratory Measurement of Direct Oral Anticoagulants, ICSH recommendations
Quality Issues :
2
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications
External quality assessment for Rivaroxaban and Dabigatran
Surveys and Studies :
1
Emicizumab pilot study, part II
Questions or suggestions?
Clotpedia Support Form
Submit
Success